A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05250817

Enrollment

501

Registered

2022-02-22

Start date

2021-12-09

Completion date

2023-01-04

Last updated

2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Keywords

Preference, Advanced/Metastatic NSCLC, Discrete choice experiment (DCE)

Brief summary

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

The following is the inclusion criteria for pretest interviews and final online survey. Participants: * Must be 18 years of age or older * Must be a US resident. * Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

Exclusion criteria

* Not applicable Other protocol-defined inclusion/

Design outcomes

Primary

Measure	Time frame
Set of relative preference weights for all attribute levels included in the Discrete Choice Experiment (DCE)	At Baseline
Respondents' baseline understanding of attribute descriptions	At Baseline

Countries

United States

Outcome results